Currently Viewing:

Top 5 AJMC® Articles of April 2019

Here are the top 5 articles for the month of April.

Hi, I’m Jaime Rosenberg for The American Journal of Managed Care. Here are the top 5 articles from the month of April.

Number 5: After a year in development, the Community Oncology Alliance is set to file its alternative to CMS’ Oncology Care Model with the Physician-Focused Payment Model Technical Advisory Committee.

Number 4: Results from a recent study indicate that a revolutionary treatment may have the potential to slow, stop, or even reverse the progression of Parkinson disease.

Number 3: Oncologists and hematologists welcomed a clarification from the CDC about the use of opioid pain relief for patients with cancer, past cancer, or sickle cell disease.

Number 2: Based on results of the REDUCE-IT study, Amarin has submitted a supplemental new drug application for an expanded label for its drug Vascepa, which was also included in a mid-year update to the American Diabetes Association’s 2019 Standards of Medical Care in Diabetes.

Number 1: Results from the CREDENCE trial demonstrated that type 2 diabetes drug canagliflozin cut the risk of renal failure or death by 30% in patients with type 2 diabetes and chronic kidney disease.

To read all of these articles and more, visit

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up